Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
24.70
-0.65 (-2.56%)
At close: Oct 29, 2025, 4:00 PM EDT
24.69
-0.01 (-0.04%)
After-hours: Oct 29, 2025, 5:22 PM EDT
Moderna Market Cap
Moderna has a market cap or net worth of $9.65 billion as of October 29, 2025. Its market cap has decreased by -56.94% in one year.
Market Cap
9.65B
Enterprise Value
2.87B
1-Year Change
-56.94%
Ranking
Category
Stock Price
$24.70
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $9.65B, an increase of 57.68%. That is a compound annual growth rate of 6.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 9.90B | -38.12% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | 41.34B | 534.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |